Exicure, Inc. (XCUR)
1.08
-0.04
(-3.57%)
USD |
NASDAQ |
Oct 19, 16:00
1.08
0.00 (0.00%)
After-Hours: 16:14
Exicure Cash from Operations (Annual) : -8.555M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -8.555M |
| December 31, 2024 | -2.91M |
| December 31, 2023 | -10.36M |
| December 31, 2022 | -36.16M |
| December 31, 2021 | -34.82M |
| December 31, 2020 | -39.27M |
| Date | Value |
|---|---|
| December 31, 2019 | 1.317M |
| December 31, 2018 | -19.49M |
| December 31, 2017 | -19.79M |
| December 31, 2016 | -5.05M |
| December 31, 2015 | -12.20M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Tenax Therapeutics, Inc. | -35.80M |
| Manhattan Scientifics, Inc. | -- |
| Century Therapeutics, Inc. | -103.88M |
| Absci Corp. | -92.92M |
| Celularity, Inc. | -13.25M |